Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Mar 31, 2005 9:14pm
87 Views
Post# 8843388

RE: withholding material info.

RE: withholding material info. Bigman... I will be the first to criticize management shortcomings but I am afraid I cant agree with you on this one. I have been directly involved in closings like this and they are often hectic and fluid. In fact, I wouldnt be surprised AT ALL if Prometic's delay in releasing their 04 financials on Tues was directly related to Hemosol's pending disclosure. I think something about it may have even been mentioned at the beginning of the PLI conference call.
Bullboard Posts